Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production
- PMID: 7825572
- PMCID: PMC1801338
Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production
Abstract
Duchenne muscular dystrophy (DMD) patients with mutations that disrupt the translational reading frame produce little or no dystrophin. Two exceptions are the deletion of exons 3-7 and the occurrence of rare dystrophin-positive fibers (revertant fibers) in muscle of DMD patients. Antibodies directed against the amino-terminus and the 5' end of exon 8 did not detect dystrophin in muscle from patients who have a deletion of exons 3-7. However, in all cases, dystrophin was detected with an antibody directed against the 3' end of exon 8. The most likely method of dystrophin production in these cases is initiation at a new start codon in exon 8. We also studied two patients who have revertant fibers: one had an inherited duplication of exons 5-7, which, on immunostaining, showed two types of revertant fibers; and the second patient had a 2-bp nonsense mutation in exon 51, which creates a cryptic splice site. An in-frame mRNA that uses this splice site in exon 51 was detected. Immunostaining demonstrated the presence of the 3' end of exon 51, which is in agreement with the use of this mRNA in revertant fibers. The most likely method of dystrophin production in these fibers is a second mutation that restores the reading frame.
Similar articles
-
Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin.Am J Hum Genet. 1995 Mar;56(3):725-31. Am J Hum Genet. 1995. PMID: 7887428 Free PMC article.
-
Exon skipping and translation in patients with frameshift deletions in the dystrophin gene.Am J Hum Genet. 1993 Nov;53(5):1007-15. Am J Hum Genet. 1993. PMID: 8213828 Free PMC article.
-
Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.JAMA Neurol. 2014 Jan;71(1):32-40. doi: 10.1001/jamaneurol.2013.4908. JAMA Neurol. 2014. PMID: 24217213 Clinical Trial.
-
[Mutation-specific treatments for Duchenne muscular dystrophy].Brain Nerve. 2009 Aug;61(8):915-22. Brain Nerve. 2009. PMID: 19697880 Review. Japanese.
-
[Molecular genetics and problems found in genetic diagnosis of Duchenne Becker muscular dystrophy].Nihon Rinsho. 1997 Dec;55(12):3120-5. Nihon Rinsho. 1997. PMID: 9436421 Review. Japanese.
Cited by
-
Interplay between DMD point mutations and splicing signals in Dystrophinopathy phenotypes.PLoS One. 2013;8(3):e59916. doi: 10.1371/journal.pone.0059916. Epub 2013 Mar 25. PLoS One. 2013. PMID: 23536893 Free PMC article.
-
MLPA-based genotype-phenotype analysis in 1053 Chinese patients with DMD/BMD.BMC Med Genet. 2013 Mar 1;14:29. doi: 10.1186/1471-2350-14-29. BMC Med Genet. 2013. PMID: 23453023 Free PMC article.
-
DMD Trp3X nonsense mutation associated with a founder effect in North American families with mild Becker muscular dystrophy.Neuromuscul Disord. 2009 Nov;19(11):743-8. doi: 10.1016/j.nmd.2009.08.010. Epub 2009 Sep 29. Neuromuscul Disord. 2009. PMID: 19793655 Free PMC article.
-
Clinical Utility Gene Card for: Becker muscular dystrophy.Eur J Hum Genet. 2018 Jul;26(7):1065-1071. doi: 10.1038/s41431-017-0064-4. Epub 2018 Feb 21. Eur J Hum Genet. 2018. PMID: 29467387 Free PMC article. No abstract available.
-
Defects in RNA splicing and the consequence of shortened translational reading frames.Am J Hum Genet. 1996 Aug;59(2):279-86. Am J Hum Genet. 1996. PMID: 8755945 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical